Foetal loss,liver necrosis and acute lupus erythematosus in a patient with antiphospholipid antibody syndrome

Abstract

The antiphospholipid antibody syndrome (APS) is characterized by arterial or venous thromboses and recurrent foetal loss. It occurs as primary disease, but also in the context of systemic lupus erythematosus (SLE). Whereas primary APS induces a thrombotic microangiopathy without significant inflammatory reaction, secondary APS in SLE is usually associated with vasculitis. Here we report a patient with APS who presented with acute diarrhoea and then developed a HELLP-like syndrome characterized by a spontaneous abortion, multifocal hepatic necroses and thrombocytopenia. Thereafter an acute flare of SLE with arthralgias, pleuritis, skin rash and glomerulitis occurred. Clinical amelioration was only achieved by combining curettage, antic-oagulation and immunosuppression, a treatment taking into account the pathogenesis of HELLPlike disease, APS and SLE. To our knowledge this is the first reported case of APS associated with combined acute manifestations of these three syndromes triggered by a presumable intestinal infection.

Keywords

antiphospholipid antibody syndrome foetal loss liver necrosis systemic lupus erythematosus infection

Get full access to this article

View all access options for this article.

References

Myones BL , McCurdy D . The antiphospholipid syndrome: immunologic and clinical aspects. Clinical spectrum and treatment . J Rheumatol 2000; 27(Suppl 58): 20–28 .

Boey ML , Colaco CB , Gharavi AE et al. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant . Br Med J (Clin Res Ed) 1983; 287: 1021–1023 .

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthrit Rheum 1999; 42: 1309–1311 .

Greaves M. Antiphospholipid antibodies and thrombosis . Lancet 1999; 353: 1348–1353 .

Tsutsumi A , Ichikawa K , Matsuura E , Koike T . Anti-beta2-glycoprotein I antibodies . Lupus 1998; 7(Suppl 2): S98–S102 .

Asherson RA , Cervera R , Piette JC et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients . Medicine (Baltimore) 1998; 77: 195–207 .

Lie JT . Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort . Lupus 1996; 5: 368–371 .

Love PE , Santoro SA . Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance . Ann Intern Med 1990; 112: 682–698 .

Alsulyman OM , Castro MA , Zuckerman E , McGehee W , Goodwin TM . Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome . Obstet Gynecol 1996; 88: 644–646 .

10.

Amant F , Spitz B , Arnout J , Van Assche FA . Hepatic necrosis and haemorrhage in pregnant patients with antiphospholipid antibodies . Lupus 1997; 6: 552–555 .

11.

Ornstein MH , Rand JH . An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases . J Rheumatol 1994; 21: 1360–1364 .

12.

Rolfes DB , Ishak KG . Liver disease in toxemia of pregnancy . Am J Gastroenterol 1986; 81: 1138–1144 .

13.

Le Huong D , Wechsler B , Vauthier-Brouzes D et al. Outcome of planned pregnancies in systemic lupus erythematosus: a prospective study on 62 pregnancies . Br J Rheumatol 1997; 36: 772–777 .

14.

Rojas-Rodriguez J , Garcia-Carrasco M , Ramos-Casals M et al. Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients . J Rheumatol 2000; 27: 238–240 .